Filing Details

Accession Number:
0001181431-12-002147
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-01-11 10:27:51
Reporting Period:
2012-01-09
Filing Date:
2012-01-11
Accepted Time:
2012-01-11 10:27:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267878 W Todd Kingma C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Executive Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-01-09 2,000 $96.47 14,543 No 4 S Direct
Common Stock Acquisiton 2012-01-10 5,411 $20.50 19,954 No 4 M Direct
Common Stock Disposition 2012-01-10 2,706 $97.80 17,248 No 4 S Direct
Common Stock Disposition 2012-01-10 2,705 $99.00 14,543 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Right to Buy Disposition 2012-01-10 5,411 $0.00 5,411 $20.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-08-30 2017-08-30 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,746 Indirect By Trust
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 2, 2011 and amended on December 7, 2011. This 10b5-1 sales plan will expire on the close of business August 16, 2012.
  2. By Trust, of which the reporting person is the Trustee.